Promising Hepatitis C Treatment’s Cure Rates, Costs Highlighted

    The Denver Post (Draper, 3/5) reported that Sovaldi (sofosbuvir) is being seen as a blockbuster medicine after studies show that it cured 90 percent of hepatitis C patients in just 12 weeks. However, a major issue with the therapy is its exorbitant cost: $1,000 a day. Insurers still have not decided about the coverage options, as more than 3 million infected patients look toward the treatment, the Post noted. The therapy received FDA approval in December.